Healthgpt Inc dba Hippocratic Ai

Healthgpt Inc. operates under the common short name Hippocratic AI, a privately held company headquartered in Palo Alto, California. Founded in 2023, Hippocratic AI has experienced rapid growth, achieving a valuation of $3.5 billion as of its November 2025 Series C funding round, bringing its total funding to $404 million. The company employs approximately 264 individuals as of early 2026.

Hippocratic AI develops safety-focused generative AI agents specifically for the healthcare sector. Their mission is to improve healthcare accessibility and patient outcomes by leveraging AI to address shortages of healthcare professionals. The company's core offerings include non-diagnostic, patient-facing clinical AI agents that handle low-risk tasks such as chronic care management, post-discharge follow-ups, medication reminders, patient intake screening, and pre-operative planning. Their technology, known as the "Polaris Safety Constellation Architecture," utilizes multiple specialized Large Language Models (LLMs) to ensure the safety and validation of patient interactions. Hippocratic AI explicitly states that its agents do not diagnose or prescribe, serving health systems, payers, and pharmaceutical firms.

In terms of patent litigation, Healthgpt Inc. dba Hippocratic AI is an operating company defending its intellectual property. The company is recorded as a defendant in one tracked case, Unified Patents v. Healthgpt Inc dba Hippocratic Ai, before the Patent Trial and Appeal Board (PTAB), filed on February 29, 2024. This indicates a challenge to the validity of a patent owned by Hippocratic AI.

The PTAB case with Unified Patents represents Hippocratic AI's sole tracked patent litigation. This aligns with the company's focus on developing proprietary AI technology, with patent applications filed for conversational AI systems.